299 related articles for article (PubMed ID: 36760507)
1. CRISPR-Cas13 in malaria parasite: Diagnosis and prospective gene function identification.
Quansah E; Chen Y; Yang S; Wang J; Sun D; Zhao Y; Chen M; Yu L; Zhang C
Front Microbiol; 2023; 14():1076947. PubMed ID: 36760507
[TBL] [Abstract][Full Text] [Related]
2. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
Kavuri NR; Ramasamy M; Qi Y; Mandadi K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
[TBL] [Abstract][Full Text] [Related]
3. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
Liu L; Pei DS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
5. CRISPR guides induce gene silencing in plants in the absence of Cas.
Sharma VK; Marla S; Zheng W; Mishra D; Huang J; Zhang W; Morris GP; Cook DE
Genome Biol; 2022 Jan; 23(1):6. PubMed ID: 34980227
[TBL] [Abstract][Full Text] [Related]
6. Cas13d: A New Molecular Scissor for Transcriptome Engineering.
Gupta R; Ghosh A; Chakravarti R; Singh R; Ravichandiran V; Swarnakar S; Ghosh D
Front Cell Dev Biol; 2022; 10():866800. PubMed ID: 35433685
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas13 System as a Promising and Versatile Tool for Cancer Diagnosis, Therapy, and Research.
Palaz F; Kalkan AK; Can Ö; Demir AN; Tozluyurt A; Özcan A; Ozsoz M
ACS Synth Biol; 2021 Jun; 10(6):1245-1267. PubMed ID: 34037380
[TBL] [Abstract][Full Text] [Related]
8. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
9. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
10. Alleviation of neurological disease by RNA editing.
Zhang S; Chen L; Zhang Y; Fang D
Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
[TBL] [Abstract][Full Text] [Related]
11. Potential Use of CRISPR/Cas13 Machinery in Understanding Virus-Host Interaction.
Bayoumi M; Munir M
Front Microbiol; 2021; 12():743580. PubMed ID: 34899631
[TBL] [Abstract][Full Text] [Related]
12. A New Method for Programmable RNA Editing Using CRISPR Effector Cas13X.1.
Li L; Liu W; Zhang H; Cai Q; Wen D; Du J; Sun J; Li L; Gao C; Lin P; Wu M; Jiang J
Tohoku J Exp Med; 2023 May; 260(1):51-61. PubMed ID: 36823185
[TBL] [Abstract][Full Text] [Related]
13. CaSilico: A versatile CRISPR package for
Asadbeigi A; Norouzi M; Vafaei Sadi MS; Saffari M; Bakhtiarizadeh MR
Front Bioeng Biotechnol; 2022; 10():957131. PubMed ID: 36017348
[TBL] [Abstract][Full Text] [Related]
14. Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing.
Tang Y; Fu Y
Cell Biosci; 2018; 8():59. PubMed ID: 30459943
[TBL] [Abstract][Full Text] [Related]
15. Expanding the plant genome editing toolbox with recently developed CRISPR-Cas systems.
Wada N; Osakabe K; Osakabe Y
Plant Physiol; 2022 Mar; 188(4):1825-1837. PubMed ID: 35099553
[TBL] [Abstract][Full Text] [Related]
16. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
Huynh N; Depner N; Larson R; King-Jones K
Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
18. In silico optimization of RNA-protein interactions for CRISPR-Cas13-based antimicrobials.
Park HM; Park Y; Berani U; Bang E; Vankerschaver J; Van Messem A; De Neve W; Shim H
Biol Direct; 2022 Oct; 17(1):27. PubMed ID: 36207756
[TBL] [Abstract][Full Text] [Related]
19. Unleashing the potential of CRISPR multiplexing: Harnessing Cas12 and Cas13 for precise gene modulation in eye diseases.
Bigini F; Lee SH; Sun YJ; Sun Y; Mahajan VB
Vision Res; 2023 Dec; 213():108317. PubMed ID: 37722240
[TBL] [Abstract][Full Text] [Related]
20. The Bacterial Enzyme Cas13 Interferes with Neurite Outgrowth from Cultured Cortical Neurons.
Wu QW; Kapfhammer JP
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33916905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]